MedicineEngineering

Matthew Peters, McKenzie Schweitzer, P. Galazka

2026.4.1Heart Failure Clinics

DOI: 10.1016/j.hfc.2025.12.001

tlooto Summary

The complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM are highlighted and emerging research and innovation that are shaping future diagnostic and therapeutic strategies are explored.

Abstract

The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.

Citation format

PETERS, Matthew; SCHWEITZER, McKenzie; GALAZKA, P. Multimodality imaging in hypertrophic cardiomyopathy. Heart Failure Clinics, 2026, 22 2(2): 221–235.